ALFA-642

N/A

Report date: 2023/05/22 10:17:33

Base Information

Drug NameALFA-642

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionGlycosaminoglycan stimulants

TargetsGlycosaminoglycan

Therapy Area/IndicationsDiabetic Nephropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEurope

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlfa Wassermann Spa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovo Nordisk A/S

Active IndicationsN/A

Inactive IndicationsDiabetic Nephropathies

Other Information

ATC CodeN/A

Related LinksN/A